Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

The management of chronic heart failure

Article Abstract:

Heart failure is caused by pathologic changes in the heart that affect its ability to pump blood. The resulting backup causes fluid to accumulate in various parts of the body. In addition, other organs are affected by the reduced blood supply. Drug therapy falls into two categories: drugs to relieve symptoms and drugs to slow progression of the disease. Symptom-relieving drugs include diuretics, vasodilators and digoxin. ACE inhibitors, hydralazine and isosorbide dinitrate can slow disease progression. Other promising drugs include beta-blockers and calcium channel blockers.

Author: Cohn, Jay N.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1996
Health aspects, Vasodilators, Vasodilator agents, Diuretics

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

Article Abstract:

A group of drugs called sartans may be as effective as ACE inhibitors for treating patients who have had a heart attack and also have heart failure, according to a study of approximately 15,000 patients. Combining both types of drug does not increase the benefit and may increase the risk of side effects. Sartans belong to a group of drugs called angiotensin-receptor blockers.

Author: Califf, Robert M., Solomon, Scott D., Pfeffer, Marc A., White, Harvey, Rouleau, Jean-Lucien, Edwards, Susan, Werf, Frans van de, McMurray, John J.V., Velazquez, Eric J., Kober, Lars, Maggioni, Aldo P., Swedberg, Karl, Leimberger, Jeffrey D., Henis, Marc, Zelenkofske, Steven, Sellers, Mary Ann
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
ACE inhibitors, Angiotensin converting enzyme inhibitors, Heart attack, Captopril

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

Article Abstract:

The drug valsartan may be effective in treating heart failure but it should not be used if the patient is also taking an ACE inhibitor and a beta blocker. This was the conclusion of a study of 5,010 patients. Valsartan belongs to a group of drugs called angiotensin-receptor blockers.

Author: Cohn, Jay N., Tognoni, Gianni
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Drug therapy, Heart failure, Evaluation, Angiotensin II receptor blockers
Similar abstracts:
  • Abstracts: Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm
  • Abstracts: Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS)
  • Abstracts: The smarter playground. A tarnished tiara. Medication mistakes
  • Abstracts: Measuring lying and standing BP. Blood pressure measurement Part 2: Using automated devices
  • Abstracts: Will the NHS ever be connected? A nurse-envisaged NHS. Opportunity knocks in anaesthetics: some trusts are breaking down traditional barriers between doctors and nurses in anaesthetics
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.